Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Showing Deep Expertise at ONS

    April 24, 2024 | CME, MedEd, Nursing, ONS2024, ONSCongress, medicaleducation, oncology 

    - PMLiVE

    The Medscape Oncology team will be connecting with the oncology nursing community this week in Washington, DC for the ONS Congress 2024. 

    Medscape Oncology has deep expertise in the oncology space, with leaders from around the world serving as faculty for their programs and impacting learners from across the care team. In 2023, the dedicated and experienced Medscape Oncology team reached 492K+ Oncology Nurse and Nurse Practitioner learners across 260 programs. 

    During ONS, Medscape will present three live symposia, covering lymphoma, multiple myeloma, and general hematology, which will specifically focus on the role of oncology nurses.  

    In addition, the Medscape Oncology team will be hosting booth #7104, from April 25-27 where they will be chatting with attendees about oncology education and the impact they are making as Medscape transforms education and imagines new possibilities. They invite attendees to stop by for more information or to take part in one of their insight surveys. 

    For more information on oncology or nurse education, please contact Chris Carey. 

    This content was provided by Medscape Education

    Company Details

    Medscape Logo

    Medscape Education

    Email
    Website

     Latest Content from  Medscape Education 

    What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?

    Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...

    DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE

    During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...

    ESMO’s New Focus on Cancer Prevention

    During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),...

    ESMO Patient Centricity – Highlights from Steve Clark

    During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK),...

    ESMO Patient Centricity Highlights from Dr. Whyte

    During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK), volunteer...

    Closing The Gaps in Patient-Centricity in Cancer Care

    Highlights from the Medscape Education full panel discussion during this year's #ESMO22.

    Full Panel Discussion: Closing The Gaps In Patient-Centricity

    On 11th September, the Medscape team came together at the Eiffel Tower for an exciting event attended by expert faculty, patient advocates and more than a hundred supporters of our...

    Medscape Education: Key Takeaways from Tapas and Trends

    This year at ESC, Medscape Education Global gathered with conference attendees and leading KOLs for an education event at the Gaudi House in Barcelona where they examined the new data...

    Medscape Education #ESC Tapas and Trends Full Panel Discussion

    This year at ESC, Medscape Education Global gathered with conference attendees and leading KOLs for an education event at the Gaudi House in Barcelona where they examined the new data...

    A Look at What’s Next After ESC

    This year at ESC, Medscape Education Global gathered with conference attendees and leading KOLs for an education event at the Gaudi House in Barcelona where they examined the new data...